Live Breaking News & Updates on Bpifrance Entreprise

Stay updated with breaking news from Bpifrance entreprise. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vinpai, the Natural Ingredients Specialist, Announces the Success of its IPO on Euronext Growth Paris

Vinpai, the Natural Ingredients Specialist, Announces the Success of its IPO on Euronext Growth Paris
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Saint Nazaire , France General , United Kingdom , United States , Saint Dolay Morbihan , Cyrille Damany , Philippe Le Ray , Philippe Le , Bpifrance Entreprise , Vinpai Group , European Union Withdrawal , Vinpai The Company Paris , Company On , European Parliament , Breakdown Of The Company , Commission Delegated Regulation , Company Board Of Directors , Financial Services , Code Of Ethics The Association Fran , Commission Delegated Directive , Company Board Of Directors On , Company Board , Extension Clause , Over Allotment Option , Initial Public Offering , Price Offering ,

Resounding Success of Pherecydes Pharma's IPO on the Euronext Growth Market in Paris

Resounding Success of Pherecydes Pharma s IPO on the Euronext Growth Market in Paris
Offer oversubscribed 4 times, with global demand totaling €28.1 million
Capital increase of approximately €8 million, after full exercise of the Extension Clause
Trading in the Company s shares begins on February 5, 2021 (FR0011651694 ALPHE)
Regulatory News:
Pherecydes Pharma (Paris:ALPHE) (FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the resounding success of its initial public offering on the Euronext Growth
market in Paris.
Guy-Charles Fanneau de La Horie, Chairman of the Executive Board of Pherecydes Pharma, says:
I am particularly sensitive to the high level of interest the financial community has shown in our IPO project, both institutional and individual investors. I would like to thank all our shareholders, longstanding and new, who h ....

United States , France General , United Kingdom , Pherecydes Pharma , Philippe Rousseau , Bpifrance Entreprise , Kostenloser Wertpapierhandel , Nicolas Merigeau , Dusan Oresansky , Entreprise Innovante , Regulations Of The French Market Authority Autorit , European Parliament , Early Access Program , Financial Services , Company Supervisory Board , Prospectus Directive Of The European Union , Document May Not Be Published , Either Directly , Charles Fanneau De La Horie , Executive Board , Global Placement , Extension Clause , Escherichia Coli , Fixed Price Offer , Euronext Growth , Supervisory Board ,